期刊文献+

恶性肿瘤与静脉血栓栓塞症 被引量:10

Malignant neoplasms and venous thromboembolism
下载PDF
导出
摘要 静脉血栓栓塞症是恶性肿瘤的主要并发症之一,也是恶性肿瘤患者死亡的主要原因,在肿瘤患者中的发病率呈增加趋势。肿瘤患者存在多个静脉血栓栓塞症的高危因素,但有效的预防和治疗可以降低发病率和病死率,现就恶性肿瘤合并静脉血栓栓塞症的病理生理机制、危险因素评估、预防和治疗做一综述。 Venous thromboembolism(VTE)is a major complication of malignant neoplasms,and is one of the leading causes of death in patients with malignant neoplasms.The incidence of VTE in this particular population is widely increasing.Several risk factors for developing venous thrombosis usually coexist in malignant neoplasms patients.Effective prophylaxis and treatment of VTE would reduce morbidity and mortality,and improve quality of life.This review will focus on the pathophysiology,risk factors,and as well as discuss the prevention and management regimens of VTE in malignant neoplasms.
出处 《临床荟萃》 CAS 2016年第4期373-377,共5页 Clinical Focus
关键词 静脉血栓栓塞症 肿瘤 并发症 预防 治疗 venous thromboembolism neoplasms complications prevention therapy
  • 相关文献

参考文献37

  • 1Chew HK, Wun T,Harvey D,et al. Incidence of venousthromboembolism and its effect on survival among patientswith common cancers [J], Arch Intern Med,2006,166 ( 4):458-464.
  • 2Falanga A. The incidence and risk of venousthromboembolism associated with cancer and nonsurgicalcancer treatment[J]. Cancer Investig,2009,27(1) : 105-115.
  • 3Horsted F,West J, Grainge MJ. Risk of venousthromboembolism in patients with cancer : a systematic reviewand meta-analysis[J]. PLoS Med,2012,9(7) : el001275.
  • 4Zwicker JI, Liebman HA, Neuberg D,et al. Tumor-derivedtissue factor-bearing microparticles are associated with venousthromboembolic events in malignancy [J]. Clin Cancer Res,2009,15(22):6830-6840.
  • 5Kakkar AK, DeRuvo N,Chinswangwatanakul V,et al.Extrinsic-pathway activation in cancer with high factor Vilaand tissue factor[J]. Lancet, 1995,346(8981) ; 1004-1005.
  • 6Hoffman R,Haim N,Brenner B. Cancer and thrombosisrevisited[J], Blood Rev,2001,15(2) :61-67.
  • 7Longenecker GL, Beyem BJ,Bowen RJ,et al. Humanrhabdosarcoma cell-induced aggregation of blood platelets[J].Cancer Res,2005 ,49(1) ; 16-19.
  • 8Rothwell PM, Wilson M, Elwin CE,et al. Long-term effectof aspirin on colorectal cancer incidence and mortality: 20-yearfollow-up of five randomized trials [J]. Lancet, 2010, 376(9754):1741-1750.
  • 9Carrier M,Le Gal G,Wells PS, et al. Systematic review: thetrousseau syndrome revisited: should we screen extensively forcancer in patients with venous thromboembolism. [J], AnnIntern Med,2008,149(5) :323-333.
  • 10Mackman N. Role of tissue factor in hemostasis, thrombosis,and vascular devel-opment [ J J, Arterioscler Thromb VaseBiol,2004,24(6) :1015-1022.

二级参考文献61

  • 1孙葵葵,王辰,古力夏提,罗琴.深静脉血栓形成的危险因素及临床分析[J].中华结核和呼吸杂志,2004,27(11):727-730. 被引量:82
  • 2王乐民.术后深静脉血栓形成和肺栓塞的防治[J].中华骨科杂志,2005,25(7):418-419. 被引量:99
  • 3高丽霞,哈力达.亚森,许风雷,王学锋,王鸿利,迪丽娜孜,陈瑢,郭新红.新疆地区动脉血栓形成患者抗活化蛋白C及FV Leiden突变的调查[J].血栓与止血学,2007,13(4):161-165. 被引量:6
  • 4Proctor MC, Greenfield LJ. Pulmonary embolism: diagnosis, incidence and implications. Cardiovasc Surg, 1997,5:77-81.
  • 5Stein PD, Patel KC, Kalra NK, et al. Deep venous thrombosis in a general hospital. Chest, 2002,122 : 960- 962.
  • 6Khorana AA, Fine RL. Pancreatic cancer and thromboembolic disease. Lancet Oncol, 2004, 5: 655- 663.
  • 7Murchison JT, Wylie L, Stockton DL. Excess risk of cancer in patients with primary venous thromboembolism: a national, population-based cohort study. Br J Cancer, 2004,91 : 92-95.
  • 8Bobek V, Kovar KJ. Antitumor and antimetastatic effect of warfarin and heparins. Biomed Pharmacother, 2004,58:213-219.
  • 9Kang MJ,Ryoo BY,Ryu MH. Venous thromboembolism (VTE) in patients with advanced gastric cancer:an Asian experience[J].European Journal of Cancer,2012,(04):492-500.
  • 10Merkow RP,Bilimoria KY,McCarter MD. Postdischarge venous thromboembolism after cancer surgery:extending the case for extended prophylaxis[J].Annals of Surgery,2011,(01):131-137.

共引文献42

同被引文献80

引证文献10

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部